The relation between thyroid function and anemia: A pooled analysis of individual participant data

Daisy M. Wopereis, Robert S. Du Puy, Diana Van Heemst, John P. Walsh, Alexandra Bremner, Stephan J.L. Bakker, Douglas C. Bauer, Anne R. Cappola, Graziano Ceresini, Jean Degryse, Robin P.F. Dullaart, Martin Feller, Luigi Ferrucci, Carmen Floriani, Oscar H. Franco, Massimo Iacoviello, Georgio Iervasi, Misa Imaizumi, J. Wouter Jukema, Kay Tee KhawRobert N. Luben, Sabrina Molinaro, Matthias Nauck, Kushang V. Patel, Robin P. Peeters, Bruce M. Psaty, Salman Razvi, Roger K. Schindhelm, Natasja M. Van Schoor, David J. Stott, Bert Vaes, Mark P.J. Vanderpump, Henry Völzke, Rudi G.J. Westendorp, Nicolas Rodondi, Christa M. Cobbaert, Jacobijn Gussekloo, Wendy P.J. Den Elzen

Research output: Contribution to journalArticleAcademicpeer-review

35 Citations (Scopus)


Context: Anemia and thyroid dysfunction often co-occur, and both increase with age. Human data on relationships between thyroid disease and anemia are scarce. Objective: To investigate the cross-sectional and longitudinal associations between clinical thyroid status and anemia. Design: Individual participant data meta-Analysis. Setting: Sixteen cohorts participating in the Thyroid Studies Collaboration (n = 42,162). Main Outcome Measures: Primary outcome measure was anemia (hemoglobin ,130 g/L in men and ,120 g/L in women). Results: Cross-sectionally, participants with abnormal thyroid status had an increased risk of having anemia compared with euthyroid participants [overt hypothyroidism, pooled OR 1.84 (95% CI 1.35 to 2.50), subclinical hypothyroidism 1.21 (1.02 to 1.43), subclinical hyperthyroidism 1.27 (1.03 to 1.57), and overt hyperthyroidism 1.69 (1.00 to 2.87)]. Hemoglobin levels were lower in all groups compared with participants with euthyroidism. In the longitudinal analyses (n = 25,466 from 14 cohorts), the pooled hazard ratio for the risk of development of anemia was 1.38 (95% CI 0.86 to 2.20) for overt hypothyroidism, 1.18 (1.00 to 1.38) for subclinical hypothyroidism, 1.15 (0.94 to 1.42) for subclinical hyperthyroidism, and 1.47 (0.91 to 2.38) for overt hyperthyroidism. Sensitivity analyses excluding thyroid medication or high levels of C-reactive protein yielded similar results. No differences in mean annual change in hemoglobin levels were observed between the thyroid hormone status groups. Conclusion: Higher odds of having anemia were observed in participants with both hypothyroid function and hyperthyroid function. In addition, reduced thyroid function at baseline showed a trend of increased risk of developing anemia during follow-up. It remains to be assessed in a randomized controlled trial whether treatment is effective in reducing anemia.

Original languageEnglish
Pages (from-to)3658-3667
Number of pages10
JournalJournal of clinical endocrinology and metabolism
Issue number10
Publication statusPublished - 1 Oct 2018

Cite this